Anika Therapeutics reported $144K in Ordinary Share Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Adamas Pharmaceuticals ADMS:US 34K 1000
Agenus AGEN:US $ 2.18M 0.22M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Anika Therapeutics ANIK:US $ 0.14M 0M
Arrowhead Research ARWR:US $ 196K 1000
Clovis Oncology CLVS:US $ 0.1M 0M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 0.91M 0M
Insmed INSM:US $ 1.03M 5K
Integra Lifesciences IART:US $ 0.89M 0M
Johnson & Johnson JNJ:US $ 3120M 0M
Karyopharm Therapeutics KPTI:US $ 8K 1000
Macrogenics MGNX:US $ 0.6M 0.04M
Merit Medical Systems MMSI:US $ 615.11M 8.89M
Rigel Pharmaceuticals RIGL:US $ 0.17M 0M
Sangamo Biosciences SGMO:US $ 1.44M 0.02M
Stryker SYK:US $ 38M 0M
Surmodics SRDX:US $ 0.69M 0.01M
Veracyte VCYT:US $ 0.06M 0M
Xencor XNCR:US $ 0.58M 0M